News | March 06, 2014

Wireless Headsets Adopted for Use in Cath and EP Labs

Quail Digital Communications Wireless Headsets Cath Lab EP Lab

March 6, 2014 — Memorial Hospital in Carbondale, Ill., has chosen Quail Digital’s healthcare wireless headset system. It will be used in catheterization and electrophysiology labs where all coronary and peripheral vascular interventions, device implants and electrophysiology procedures are performed.

Quail Digital wireless headsets are worn by all staff, including physicians, to ensure everyone is kept in the communication loop during procedures. The Quail Digital system’s hands free, digital design ensures ease of use with excellent audio quality, even with multiple systems being used in the same facility.

Nine headsets were installed for use in four catheterization and electrophysiology labs.

Mike Bull, cath lab manager, said, “Our teams like the headsets and we’ve found that communication has improved during our procedures thanks to the system.  It is now much easier for our staff monitoring the procedure from the control to hear what is happening in the lab, and their documentation is more accurate and thorough as a result. The headset system has been a good investment and we are very happy with the improved communication and the associated benefits.”

Outside healthcare, brands using Quail Digital systems include: IKEA, The Co-operative, Sainsbury’s, McDonald’s, KFC, Burger King, Sonic, Popeyes, Edeka, Bauhaus, Starbucks, Taco Bell, Gap.

For more information: www.quaildigital.com

Related Content

Biotronik Launches DX Technology for U.S. Heart Failure Patients
News | Cardiac Resynchronization Therapy Devices (CRT)| July 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX and Intica...
First Patient Treated in U.S. Feasibility Study of LimFlow Critical Limb Ischemia Device
News | Peripheral Arterial Disease (PAD)| July 17, 2017
LimFlow SA announced enrollment of the first patient in the U.S. feasibility study of the LimFlow Percutaneous Deep...
FDA Approves Six-Month Primary Endpoint for Tack Endovascular System in Below the Knee Disease
News | Stents Peripheral| July 14, 2017
Intact Vascular Inc. announced the U.S. Food and Drug Administration (FDA) approved an Investigational Device Exemption...
Edwards Sapien 3 TAVR valve will be implanted in asymptomatic aortic stenosis patients in the EARLY TAVR Trial
Feature | Heart Valve Technology| July 14, 2017
July 14, 2017 — Morristown Medical Center, part of Atlantic Health System, has randomized the first patient in the wo
Cardiologs ECG Analysis Platform Receives FDA Clearance
Technology | ECG Monitoring Services| July 13, 2017
Cardiologs Technologies SAS announced that it has received U.S. Food and Drug Administration (FDA) clearance of its...
long-duration dual anti-platelet therapy (L-DAPT) compared to short-duration dual antiplatelet (S-DAPT) after DES stent implantation
News | Antiplatelet and Anticoagulation Therapies| July 12, 2017
June 12, 2017 — Researchers have evaluated the long-term efficacy and safety of long-duration dual anti-platelet ther
iRhythm and Stanford Researchers Develop Deep Learning-Based Cardiac Arrhthymia Detection Algorithm
News | Artificial Intelligence| July 11, 2017
iRhythm Technologies Inc. announced a collaboration with the Stanford Machine Learning Group that has resulted in the...
Medtronic's CoreValve Evolut R gained FDA approval for intermediate risk patients

An illustration of the self-expanding CoreValve Evolut R TAVR valve half deployed in the aortic root.

Feature | Heart Valve Technology| July 10, 2017
The U.S. Food and Drug Administration (FDA) has cleared an additional indication to expand the use Medtronic's self-...
Overlay Init